Argyle Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Buy
10,700
+2,900
+37% +$212K 0.21% 98
2026
Q1
$595K Buy
7,800
+3,335
+75% +$240K 0.19% 103
2025
Q4
$285K Hold
4,465
0.1% 125
2025
Q3
$282K Hold
4,465
0.1% 122
2025
Q2
$333K Buy
4,465
+1,000
+29% +$78.6K 0.12% 117
2025
Q1
$305K Buy
3,465
+689
+25% +$65.1K 0.11% 118
2024
Q4
$254K Buy
2,776
+311
+13% +$31.9K 0.1% 120
2024
Q3
$276K Sell
2,465
-935
-28% -$93.5K 0.11% 113
2024
Q2
$333K Hold
3,400
0.14% 111
2024
Q1
$341K Hold
3,400
0.13% 104
2023
Q4
$305K Hold
3,400
0.13% 101
2023
Q3
$261K Hold
3,400
0.1% 112
2023
Q2
$285K Hold
3,400
0.1% 110
2023
Q1
$287K Hold
3,400
0.1% 116
2022
Q4
$277K Hold
3,400
0.1% 116
2022
Q3
$242K Hold
3,400
0.09% 118
2022
Q2
$305K Hold
3,400
0.11% 116
2022
Q1
$381K Hold
3,400
0.12% 112
2021
Q4
$411K Hold
3,400
0.13% 110
2021
Q3
$343K Hold
3,400
0.11% 114
2021
Q2
$397K Hold
3,400
0.13% 113
2021
Q1
$374K Hold
3,400
0.13% 114
2020
Q4
$341K Hold
3,400
0.13% 110
2020
Q3
$266K Hold
3,400
0.11% 114
2020
Q2
$237K Buy
+3,400
New +$214K 0.1% 113
2020
Q1
Sell
-3,400
Closed -$269K 125
2019
Q4
$269K Hold
3,400
0.1% 118
2019
Q3
$251K Hold
3,400
0.09% 117
2019
Q2
$265K Hold
3,400
0.1% 116
2019
Q1
$258K Hold
3,400
0.1% 113
2018
Q4
$249K Hold
3,400
0.11% 109
2018
Q3
$325K Hold
3,400
0.12% 107
2018
Q2
$340K Hold
3,400
0.13% 106
2018
Q1
$359K Hold
3,400
0.14% 107
2017
Q4
$315K Hold
3,400
0.12% 111
2017
Q3
$308K Hold
3,400
0.12% 110
2017
Q2
$286K Hold
3,400
0.12% 111
2017
Q1
$275K Hold
3,400
0.11% 112
2016
Q4
$256K Hold
3,400
0.11% 113
2016
Q3
$230K Hold
3,400
0.1% 112
2016
Q2
$231K Hold
3,400
0.1% 110
2016
Q1
$246K Hold
3,400
0.11% 108
2015
Q4
$230K Hold
3,400
0.11% 110
2015
Q3
$220K Buy
+3,400
New +$251K 0.11% 110

Other funds holding EMN

Argyle Capital Management's EMN Position: Q2 2026 in Review

Argyle Capital Management increased its Eastman Chemical (EMN) stake by 37% in Q2 2026, buying an estimated $212K and bringing the position to 10,700 shares worth $717K. The position accounts for 0.21% of the portfolio, ranked #98.

Argyle Capital Management first reported a position in EMN in Q3 2015 and has held it in 43 quarters since. 217 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Argyle Capital Management held 10,700 shares of Eastman Chemical worth $717K as of Q2 2026.
  • Argyle Capital Management bought 2,900 Eastman Chemical shares in Q2 2026, an estimated $212K.
  • Eastman Chemical made up 0.21% of Argyle Capital Management's portfolio in Q2 2026, its #98 holding.
  • Argyle Capital Management first reported a position in Eastman Chemical in Q3 2015 and has held it in 43 quarters since.
  • 217 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Argyle Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.